Study on the Feasibility of Continuous Glucose Monitoring(CGM) for Improving Blood Glucose Control in Severe Patients

Launched by CHINESE MEDICAL ASSOCIATION · May 3, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of Continuous Glucose Monitoring (CGM) to help improve blood sugar control in patients who are critically ill. Unlike traditional methods that check blood sugar levels a few times a day, CGM provides real-time glucose readings and can alert patients if their levels are too high or too low. This could help patients make quicker decisions about their diet or medication. The trial aims to see if using CGM can help these patients maintain better blood sugar levels, which is important for their recovery.

To participate in this study, you need to be between 18 and 80 years old and have been in the Intensive Care Unit (ICU) for less than 48 hours, with an expected stay of more than 24 hours. The study is currently looking for participants, and they will be monitored closely throughout the trial. It's important to note that some health conditions, like local infections or recent surgeries, may prevent you from joining. This study could offer valuable insights into how CGM can benefit patients in critical care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age≥ 18 years and \< 80 years
• • ICU stay ≤48 hours
• • Expected ICU stay \> 24 hours
• • APACHE II score≥ 8
• Exclusion Criteria:
• • local infection within the sensor placement area
• • Laparotomy within lower abdomen
• • Participated in this study before
• • In other clinical trails.